{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:21:11Z","timestamp":1791238871462,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Safe, effective and affordable drug combinations against falciparum malaria are urgently needed for the poor populations in malaria endemic countries. Methylene blue (MB) combined with chloroquine (CQ) has been considered as one promising new regimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>The primary objective of this study was to evaluate the safety of CQ-MB in African children with uncomplicated falciparum malaria. Secondary objectives were to assess the efficacy and the acceptance of CQ-MB in a rural population of West Africa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this hospital-based randomized controlled trial, 226 children (6\u201359 months) with uncomplicated falciparum malaria were treated in Burkina Faso. The children were 4:1 randomized to CQ-MB (n = 181; 25 mg\/kg CQ and 12 mg\/kg MB over three days) or CQ (n = 45; 25 mg\/kg over three days) respectively. The primary outcome was the incidence of severe haemolysis or other serious adverse events (SAEs). Efficacy outcomes were defined according to the WHO 2003 classification system. Patients were hospitalized for four days and followed up until day 14.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>No differences in the incidence of SAEs and other adverse events were observed between children treated with CQ-MB (including 24 cases of G6PD deficiency) compared to children treated with CQ. There was no case of severe haemolysis and also no significant difference in mean haemoglobin between study groups. Treatment failure rates were 53.7% (95% CI [37.4%; 69.3%]) in the CQ group compared to 44.0% (95% CI [36.3%; 51.9%]) in the CQ-MB group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>MB is safe for the treatment of uncomplicated falciparum malaria, even in G6PD deficient African children. However, the efficacy of the CQ-MB combination has not been sufficient at the MB dose used in this study. Future studies need to assess the efficacy of MB at higher doses and in combination with appropriate partner drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-4-45","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T18:18:10Z","timestamp":1127413090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]"],"prefix":"10.1186","volume":"4","author":[{"given":"Peter E","family":"Meissner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germain","family":"Mandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Rengelshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Sanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9ophile","family":"Tapsoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Walter-Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Mikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Burhenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Dieter","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bocar","family":"Kouyat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,22]]},"reference":[{"key":"160_CR1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1046\/j.1365-3156.2001.00804.x","volume":"6","author":"L Amaral","year":"2001","unstructured":"Amaral L, Viveiros M, Kristiansen JE: Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries. Trop Med Int Health. 2001, 6: 1016-1022. 10.1046\/j.1365-3156.2001.00804.x.","journal-title":"Trop Med Int Health"},{"key":"160_CR2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood.V32.5.816.816","volume":"32","author":"E Beutler","year":"1968","unstructured":"Beutler E, Mitchell M: Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood. 1968, 32: 816-818.","journal-title":"Blood"},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","volume":"84","author":"E Beutler","year":"1994","unstructured":"Beutler E: G6PD deficiency. Blood. 1994, 84: 3613-3636.","journal-title":"Blood"},{"key":"160_CR4","first-page":"1378","volume":"78","author":"PB Bloland","year":"2000","unstructured":"Bloland PB, Ettling M, Meek S: Combination therapy for malaria in Africa: hype or hope?. Bull World Health Organ. 2000, 78: 1378-1388.","journal-title":"Bull World Health Organ"},{"issue":"Suppl 2","key":"160_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2004.71.2_suppl.0700001","volume":"71","author":"JG Breman","year":"2004","unstructured":"Breman JG, Alilio MS, Mills A: Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg. 2004, 71 (Suppl 2): 1-15.","journal-title":"Am J Trop Med Hyg"},{"key":"160_CR6","volume-title":"Dissertation","author":"B Coulibaly","year":"2004","unstructured":"Coulibaly B: Malaria-related studies on enzymopathies, methaemoglobin, and methylene blue. Dissertation. 2004, Heidelberg University"},{"key":"160_CR7","first-page":"285","volume-title":"Health research in developing countries","author":"B Coulibaly","year":"2005","unstructured":"Coulibaly B, Eubel J, Gromer S, Schirmer RH: Biochemistry-based health care research. Methylene blue, malaria, methaemoglobin, and malnutrition. Health research in developing countries. Edited by: Becher H, Kouyat\u00e9 B. 2005, Springer Verlag Berlin Heidelberg, 285-292."},{"key":"160_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D: A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001, 344: 257-263. 10.1056\/NEJM200101253440403.","journal-title":"N Engl J Med"},{"key":"160_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0140-6736(01)38705-6","volume":"182","author":"P Ehrlich","year":"1913","unstructured":"Ehrlich P: Chemotherapeutics: scientific principles, methods, and results. Lancet. 1913, 182: 445-451. 10.1016\/S0140-6736(01)38705-6.","journal-title":"Lancet"},{"key":"160_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0014-5793(98)00031-3","volume":"422","author":"PM F\u00e4rber","year":"1998","unstructured":"F\u00e4rber PM, Arscott LD, Williams CH, Becker K, Schirmer RH: Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Letters. 1998, 422: 311-314. 10.1016\/S0014-5793(98)00031-3.","journal-title":"FEBS Letters"},{"key":"160_CR11","first-page":"488","volume-title":"Rev Ther Med Chir","author":"C Ferreira","year":"1893","unstructured":"Ferreira C: Sur l'emploi du bleu de m\u00e9thyl\u00e8ne dans la malaria infantile. Rev Ther Med Chir. 1893, 488-525."},{"key":"160_CR12","first-page":"208","volume-title":"Manson's Tropical Diseases","author":"AF Fleming","year":"2003","unstructured":"Fleming AF, de Silva PS: G6PD deficiency. Manson's Tropical Diseases. Edited by: Cook GC, Zumla A. 2003, Elsevier Science Ltd, Edinburgh, UK, 208-212."},{"key":"160_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1179\/135100003225002907","volume":"8","author":"Ginsburg","year":"2003","unstructured":"Ginsburg , Golenser J: Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium. Redox Rep. 2003, 8: 276-279. 10.1179\/135100003225002907.","journal-title":"Redox Rep"},{"key":"160_CR14","first-page":"953","volume":"28","author":"P Guttmann","year":"1891","unstructured":"Guttmann P, Ehrlich P: \u00dcber die Wirkung des Methylenblau bei Malaria. Berliner Klinische Wochenschrift. 1891, 28: 953-956.","journal-title":"Berliner Klinische Wochenschrift"},{"key":"160_CR15","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMcps040669","volume":"351","author":"WJ Janssen","year":"2004","unstructured":"Janssen WJ, Dhaliwal G, Collard HR, Saint S: Clinical problem-solving. Why \"why\" matters. N Engl J Med. 2004, 351: 2429-2434. 10.1056\/NEJMcps040669.","journal-title":"N Engl J Med"},{"key":"160_CR16","first-page":"34","volume-title":"Grundriss der klinischen Therapie innerer Erkrankungen, 2","author":"G Klemperer","year":"1924","unstructured":"Klemperer G: Grundriss der klinischen Therapie innerer Erkrankungen, 2. 1924, Auflage, Urban und Schwarzenberg, Berlin und Wien, 34-35."},{"key":"160_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-2141.1999.01230.x","volume":"104","author":"R Kotea","year":"1999","unstructured":"Kotea R, Kaeda JS, Yan SLK, Sem Fa N, Beesoon S, Jankee S, Ramasawmy R, Vulliamy T, Bradnock RW, Bautista J, Luzzatto L, Krishnamoorthy R, Mason PJ: Three major G6PD-deficient polymorphic variants identified among the Mauritian population. Br J Haematol. 1999, 104: 849-854. 10.1046\/j.1365-2141.1999.01230.x.","journal-title":"Br J Haematol"},{"key":"160_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0140-6736(94)91839-2","volume":"343","author":"A K\u00fcpfer","year":"1994","unstructured":"K\u00fcpfer A, Aeschlimann C, Wermuth B, Cerny T: Prophylaxis and reversal of ifosfamide encephalopathy with methylene blue. Lancet. 1994, 343: 763-764. 10.1016\/S0140-6736(94)91839-2.","journal-title":"Lancet"},{"key":"160_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1473-3099(03)00547-4","volume":"3","author":"T Lang","year":"2003","unstructured":"Lang T, Greenwood B: The development of Lapdap, an affordable new treatment for malaria. Lancet Infect Dis. 2003, 3: 162-168. 10.1016\/S1473-3099(03)00547-4.","journal-title":"Lancet Infect Dis"},{"key":"160_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-3156.2004.01356.x","volume":"10","author":"G Mandi","year":"2005","unstructured":"Mandi G, Witte S, Meissner P, Coulibaly B, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Sanon M, Wust K, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer H, Kouyate B, Muller O: Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Trop Med Int Health. 2005, 10: 32-38. 10.1111\/j.1365-3156.2004.01356.x.","journal-title":"Trop Med Int Health"},{"key":"160_CR21","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1055\/s-0028-1138019","volume":"45","author":"M Mayer","year":"1919","unstructured":"Mayer M: \u00dcber die Wirkung von Methylenblau bei Malaria quartana. Dtsch Med Wochenschrift. 1919, 45: 1052-1053.","journal-title":"Dtsch Med Wochenschrift"},{"key":"160_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/bj20020962","volume":"368","author":"S Meierjohann","year":"2002","unstructured":"Meierjohann S, Walter RD, M\u00fcller S: Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem J. 2002, 368: 761-768. 10.1042\/BJ20020962.","journal-title":"Biochem J"},{"key":"160_CR23","volume-title":"Br J Haematol","author":"P Meissner","year":"2005","unstructured":"Meissner P, Coulibaly B, Mandi G, Mansmann U, Witte S, Schiek W, M\u00fcller O, Schirmer RH, Mockenhaupt FP, Bienzle U: Diagnosis of red cell G6PD deficiency in rural Burkina Faso. Comparison of a rapid fluorescent enzyme test on filter paper with PCR based genotyping. Br J Haematol. 2005,"},{"key":"160_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0035-9203(01)90141-5","volume":"95","author":"D Modiano","year":"2001","unstructured":"Modiano D, Luoni G, Sirima BS, Lanfrancotti A, Petrarca V, Cruciani F, Simpore J, Ciminelli BM, Foglietta E, Grisanti P, Bianco I, Modiano G, Coluzzi M: The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso (West Africa) is associated with low frequencies of classic malaria-resistance genes. Trans R Soc Trop Med Hyg. 2001, 95: 149-152. 10.1016\/S0035-9203(01)90141-5.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"160_CR25","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/bmj.322.7302.1567","volume":"322","author":"O M\u00fcller","year":"2001","unstructured":"M\u00fcller O, Becher H, Baltussen A, Ye Y, Diallo DA, Konate AT, Gbangou A, Kouyate B, Garenne M: Effect of zinc supplementation on malaria morbidity among West African children: a randomized double-blind placebo-controlled trial. BMJ. 2001, 322: 1567-1572. 10.1136\/bmj.322.7302.1567.","journal-title":"BMJ"},{"key":"160_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1365-3156.2003.01030.x","volume":"8","author":"O M\u00fcller","year":"2003","unstructured":"M\u00fcller O, Traor\u00e9 C, Kouyat\u00e9 B, Becher H: Malaria morbidity, treatment seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso. Trop Med Int Health. 2003, 8: 290-296. 10.1046\/j.1365-3156.2003.01030.x.","journal-title":"Trop Med Int Health"},{"key":"160_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1046\/j.1365-3156.2003.01018.x","volume":"8","author":"O M\u00fcller","year":"2003","unstructured":"M\u00fcller O, Traor\u00e9 C, Kouyat\u00e9 B: Clinical efficacy of chloroquine in young children with uncomplicated malaria \u2013 a community based study in rural Burkina Faso. Trop Med Int Health. 2003, 8: 202-203. 10.1046\/j.1365-3156.2003.01018.x.","journal-title":"Trop Med Int Health"},{"key":"160_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2165\/00003495-200262090-00003","volume":"62","author":"F Nosten","year":"2002","unstructured":"Nosten F, Brasseur P: Combination therapy for malaria. Drugs. 2002, 62: 1315-1329.","journal-title":"Drugs"},{"key":"160_CR29","first-page":"381","volume":"3","author":"JB Ouedraogo","year":"1998","unstructured":"Ouedraogo JB, Dutheil Y, Tinto H, Traore B, Zampa H, Tall F, Coulibaly SO, Guiguemde TR: In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa). Trop Med Int Health. 1998, 3: 381-384.","journal-title":"Trop Med Int Health"},{"key":"160_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00228-004-0818-0","volume":"60","author":"J Rengelshausen","year":"2004","unstructured":"Rengelshausen J, Burhenne J, Fr\u00f6hlich M, Tayrouz Y, Singh SK, Riedel KD, Muller O, Hoppe-Tichy T, Haefeli WE, Mikus G, Walter-Sack I: Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur J Clin Pharm. 2004, 60: 709-715. 10.1007\/s00228-004-0818-0.","journal-title":"Eur J Clin Pharm"},{"key":"160_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0022-2836(03)00347-4","volume":"328","author":"GN Sarma","year":"2003","unstructured":"Sarma GN, Savvides SN, Becker K, Schirmer M, Schirmer RH, Karplus PA: Glutathione reductase of the malarial parasite Plasmodium falciparum: Crystal structure and inhibitor development. J Mol Biol. 2003, 328: 893-907. 10.1016\/S0022-2836(03)00347-4.","journal-title":"J Mol Biol"},{"key":"160_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1179\/135100003225002899","volume":"8","author":"RH Schirmer","year":"2003","unstructured":"Schirmer RH, Coulibaly B, Stich A, Scheiwein M, Merkle H, Eubel J, Becker K, Becher H, Muller O, Zich T, Schiek W, Kouyate B: Methylene blue as an antimalarial agent. Redox Rep. 2003, 8: 272-276. 10.1179\/135100003225002899.","journal-title":"Redox Rep"},{"key":"160_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0035-9203(03)90166-0","volume":"97","author":"SB Sirima","year":"2003","unstructured":"Sirima SB, Tiono AB, Konate A, Diarra A, Castelli F, Pinoges L, Mugittu K, Taylor WR, Olliaros PL: Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial. Trans R Soc Trop Med Hyg. 2003, 97: 345-349. 10.1016\/S0035-9203(03)90166-0.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"160_CR34","first-page":"624","volume":"77","author":"RW Snow","year":"1999","unstructured":"Snow RW, Craig M, Deichmann U, Marsh K: Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999, 77: 624-640.","journal-title":"Bull World Health Organ"},{"key":"160_CR35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1365-3156.2002.00952.x","volume":"7","author":"H Tinto","year":"2002","unstructured":"Tinto H, Zoungrana EB, Coulibaly SO, Ouedraogo JB, Traore M, Guiguemde TR, Van Marck E, D'Alessandro U: Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998\u20132000. Trop Med Int Health. 2002, 7: 925-930. 10.1046\/j.1365-3156.2002.00952.x.","journal-title":"Trop Med Int Health"},{"issue":"suppl","key":"160_CR36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","volume":"64","author":"J Trape","year":"2001","unstructured":"Trape J: The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001, 64 (suppl): 12-17.","journal-title":"Am J Trop Med Hyg"},{"key":"160_CR37","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(98)07367-X","volume":"353","author":"NJ White","year":"1999","unstructured":"White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P: Averting a malaria disaster. Lancet. 1999, 353: 1965-1967. 10.1016\/S0140-6736(98)07367-X.","journal-title":"Lancet"},{"key":"160_CR38","first-page":"269","volume":"72","author":"WHO","year":"1997","unstructured":"WHO: World malaria situation 1994. Weekly Epid Rec. 1997, 72: 269-292.","journal-title":"Weekly Epid Rec"},{"key":"160_CR39","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","author":"WHO","year":"2003","unstructured":"WHO: Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. 2003, World Health Organization, Geneva, WHO\/HTM\/RBM\/2003.50"},{"key":"160_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1473-3099(01)00119-0","volume":"1","author":"P Winstanley","year":"2001","unstructured":"Winstanley P: Modern chemotherapeutic options for malaria. Lancet Infect Dis. 2001, 1: 242-250. 10.1016\/S1473-3099(01)00119-0.","journal-title":"Lancet Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-4-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:05:38Z","timestamp":1630458338000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-4-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-4-45","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,22]]},"assertion":[{"value":"7 July 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}